Clinical Trials Logo

Clinical Trial Summary

The study is investigator initiated. Tumors that gives the narrowing of the bile ducts prevents bile from flowing from the liver to the intestine resulting in jaundice and the risk of bacterial growth in bile with severe infections as a result. Unresectable bile duct strictures have routinely been treated them with plastic stents. The plastic stents have been replaced by self expandable metallic stents.

These stents remain open longer for reasons that they have a larger diameter so that the bile flows through more easily. One problem with these stents, however, is that the tumor growing through the wire mesh which forms the wall of the stent. This has led to the development of so-called covered stents. Whether covered stents have longer patency is unclear as well as whether they are as safe. There is reason to believe that covered stents remain open longer, but there may be an increased risk of migration and other complications.

The purpose is to prospectively and randomized compare the two stent types. The study endpoint is the clogging of the stent or the patient's death. We also monitor complications, regress time of the jaundice and success rate of stent placement


Clinical Trial Description

0 ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01232101
Study type Interventional
Source Göteborg University
Contact
Status Completed
Phase N/A
Start date March 2007
Completion date August 2009

See also
  Status Clinical Trial Phase
Recruiting NCT05600803 - Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
Recruiting NCT05286814 - M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma Phase 2
Recruiting NCT06115655 - A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles
Enrolling by invitation NCT03951324 - Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
Active, not recruiting NCT05374122 - AI Guidance for Biopsy in Suspected Cholangiocarcinoma N/A
Terminated NCT04276090 - Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma N/A
Active, not recruiting NCT00582647 - Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Recruiting NCT00915863 - Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy N/A
Recruiting NCT05172310 - PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI Phase 1
Recruiting NCT05320328 - RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION
Completed NCT01845337 - Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine Phase 2
Completed NCT04847167 - Mechanistic Loop Resolution Strategy for Short-type Single Balloon Enteroscopy N/A
Completed NCT00634751 - CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma Phase 1/Phase 2
Not yet recruiting NCT03838913 - Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)